Based on previous studies and on our results, TSC mutation induces an imbalance in the antioxidant system of cancer cells, and the increased activity of TrxR and Prdx5 enzymes compensate for the elevated levels of ROS production and maintain an increased proliferative capacity, protecting the cells from ER stress-induced death. This evidence concerns the gene TSC1 and cancer.